Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes.

Kato K, Yoshimi A, Ito E, Oki K, Hara J, Nagatoshi Y, Kikuchi A, Kobayashi R, Nagamura-Inoue T, Kai S, Azuma H, Takanashi M, Isoyama K, Kato S; Japan Cord Blood Bank Network.

Biol Blood Marrow Transplant. 2011 Dec;17(12):1814-21. doi: 10.1016/j.bbmt.2011.05.013. Epub 2011 May 25.

2.

Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up.

Iori AP, Arcese W, Milano F, Calabrese E, Torelli GF, Barberi W, Mascolo MG, De Felice L, Screnci M, Lucarelli B, Malandruccolo L, Perrone MP, Salvatori S, Laurenti L, Iannella E, Ricci R, Moleti ML, Foà R.

Haematologica. 2007 Aug;92(8):1051-8. Epub 2007 Jul 20.

3.

Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.

Koh LP, Chen CS, Tai BC, Hwang WY, Tan LK, Ng HY, Linn YC, Koh MB, Goh YT, Tan B, Lim S, Lee YM, Tan KW, Liu TC, Ng HJ, Loh YS, Mow BM, Tan DC, Tan PH.

Biol Blood Marrow Transplant. 2007 Jul;13(7):790-805. Epub 2007 Apr 23.

4.

Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.

Ferrá C, Sanz J, de la Cámara R, Sanz G, Bermúdez A, Valcárcel D, Rovira M, Serrano D, Caballero D, Espigado I, Morgades M, Heras I, Solano C, Duarte R, Barrenetxea C, García-Noblejas A, Díez-Martin JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Ribera JM; GETH (Grupo Español de Trasplante Hematopoyético) and PETHEMA (Programa Español de Tratamiento en Hematología), Spanish Society of Hematology.

Biol Blood Marrow Transplant. 2010 Jul;16(7):957-66. doi: 10.1016/j.bbmt.2010.02.003. Epub 2010 Feb 7.

5.

Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation.

Berglund S, Le Blanc K, Remberger M, Gertow J, Uzunel M, Svenberg P, Winiarski J, Ljungman P, Ringdén O, Uhlin M, Mattsson J.

Transplantation. 2012 Nov 27;94(10):1066-74. doi: 10.1097/TP.0b013e31826c39b2.

PMID:
23076550
7.

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, Remberger M, Michel G, Arcese W, Dallorso S, Tiedemann K, Busca A, Chan KW, Kato S, Ortega J, Vowels M, Zander A, Souillet G, Oakill A, Woolfrey A, Pay AL, Green A, Garnier F, Ionescu I, Wernet P, Sirchia G, Rubinstein P, Chevret S, Gluckman E.

Blood. 2001 May 15;97(10):2962-71.

8.

Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.

Jacobsohn DA, Hewlett B, Ranalli M, Seshadri R, Duerst R, Kletzel M.

Bone Marrow Transplant. 2004 Nov;34(10):901-7.

PMID:
15361908
9.

Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.

Wang X, Liu H, Li L, Geng L, Ding K, Liu X, Tong J, Zhu W, Sun Z.

Eur J Haematol. 2012 Jan;88(1):39-45. doi: 10.1111/j.1600-0609.2011.01709.x. Epub 2011 Nov 15.

PMID:
21933279
10.

Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.

Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M.

Biol Blood Marrow Transplant. 2008 May;14(5):568-75. doi: 10.1016/j.bbmt.2008.02.018.

11.

Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group.

Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M, Messina C, Ortega J, Badell-Serra I, Plouvier E, Souillet G, Jouet JP, Pasquini R, Ferreira E, Garnier F, Gluckman E.

Blood. 1999 Jun 1;93(11):3662-71.

12.
13.

Long-term outcome of cord blood transplantation from unrelated donors as an initial transplantation procedure for children with AML in Japan.

Isoyama K, Oda M, Kato K, Nagamura-Inoue T, Kai S, Kigasawa H, Kobayashi R, Mimaya J, Inoue M, Kikuchi A, Kato S; Japan Cord Blood Bank Network.

Bone Marrow Transplant. 2010 Jan;45(1):69-77. doi: 10.1038/bmt.2009.93. Epub 2009 May 11.

PMID:
19430503
14.

Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults.

Narimatsu H, Terakura S, Matsuo K, Oba T, Uchida T, Iida H, Hamaguchi M, Watanabe M, Kohno A, Murata M, Sawa M, Miyamura K, Morishita Y.

Bone Marrow Transplant. 2007 Jan;39(1):31-9. Epub 2006 Nov 20.

PMID:
17115066
15.

The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis.

Nishihira H, Kato K, Isoyama K, Takahashi TA, Kai S, Kato S, Takanashi M, Sato N, Sato H, Kitajima K, Naoe T, Saito H.

Br J Haematol. 2003 Feb;120(3):516-22.

PMID:
12580971
16.

Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies.

Ohnuma K, Isoyama K, Ikuta K, Toyoda Y, Nakamura J, Nakajima F, Tsuchida M, Ohira M, Suminoe A, Hara T, Nishihira H.

Br J Haematol. 2001 Mar;112(4):981-7.

PMID:
11298596
17.

Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.

Mori T, Tanaka M, Kobayashi T, Ohashi K, Fujisawa S, Yokota A, Fujita H, Nakaseko C, Sakura T, Nannya Y, Takahashi S, Kanamori H, Kanda Y, Sakamaki H, Okamoto S; Kanto Study Group for Cell Therapy.

Biol Blood Marrow Transplant. 2013 Mar;19(3):486-91. doi: 10.1016/j.bbmt.2012.12.007. Epub 2012 Dec 16.

18.

Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.

Wall DA, Carter SL, Kernan NA, Kapoor N, Kamani NR, Brochstein JA, Frangoul H, Goyal RK, Horan JT, Pietryga D, Wagner JE, Kurtzberg J; COBLT Steering Committee.

Biol Blood Marrow Transplant. 2005 Aug;11(8):637-46.

19.

Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome.

Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C, Fagioli F, Porta F, Favre C, Pession A, Locatelli F; AIEOP-BMT Group. Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplant.

Blood. 2002 Aug 15;100(4):1192-200.

20.

Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.

Haematologica. 2002 Jan;87(1):52-8.

Supplemental Content

Support Center